BRIEF published on 05/31/2024 at 17:03, 1 year 8 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA FDA Approval Moderna Vaccine RSV MRESVIA
BRIEF published on 05/31/2024 at 17:03, 1 year 8 months ago Moderna reçoit l'approbation de la FDA américaine pour le vaccin contre le RSV mRESVIA Approbation De La FDA Moderne VRS MRESVIA Vaccin
PRESS RELEASE published on 05/31/2024 at 16:58, 1 year 8 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) Moderna gains FDA approval for mRESVIA, a single-dose pre-filled syringe RSV vaccine for adults 60+ to prevent lower respiratory tract disease. Second mRNA product and breakthrough therapy designation FDA Approval Moderna RSV Vaccine MRNA MRESVIA
BRIEF published on 05/22/2024 at 13:05, 1 year 8 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Clinical Trials Immunotherapy Moderna ASCO 2024 MRNA-4157
BRIEF published on 05/22/2024 at 13:05, 1 year 8 months ago Moderna annonce que les données seront présentées lors de l'assemblée annuelle 2024 de l'ASCO Immunothérapie Essais Cliniques Moderne ASCO 2024 ARNm-4157
PRESS RELEASE published on 05/22/2024 at 13:00, 1 year 8 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF published on 05/13/2024 at 13:05, 1 year 8 months ago Moderna Announces Participation in Key Investor Conferences Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF published on 05/13/2024 at 13:05, 1 year 8 months ago Moderna annonce sa participation à des conférences clés pour les investisseurs Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE published on 05/13/2024 at 13:00, 1 year 8 months ago Moderna to Present at Upcoming Conferences in May/June 2024 Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF published on 05/02/2024 at 12:35, 1 year 8 months ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
Published on 02/02/2026 at 00:05, 3 hours 24 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 1 hour ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 02:50, 39 minutes ago Xinhua Silk Road: Ecosystem and sustainability redefine global automotive brand value: report
Published on 02/01/2026 at 20:25, 7 hours 4 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 11 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 15 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/30/2026 at 18:40, 2 days 8 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 9 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 18 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
